Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.79
-1.11 (-8.60%)
At close: Mar 11, 2026, 4:00 PM EDT
12.02
+0.23 (1.95%)
After-hours: Mar 11, 2026, 7:28 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $206.03 million as of March 11, 2026. Its market cap has increased by 107.69% in one year.
Market Cap
206.03M
Enterprise Value
200.48M
1-Year Change
107.69%
Ranking
Category
Stock Price
$11.79
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $206.03M, a decrease of -34.01%. That is a compound annual growth rate of -13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 225.43M | 62.06% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 215.98M |
| ProMIS Neurosciences | 213.16M |
| Arcturus Therapeutics Holdings | 209.19M |
| Tenaya Therapeutics | 207.33M |
| Compugen | 203.29M |
| ProQR Therapeutics | 199.10M |
| NeOnc Technologies Holdings | 193.21M |
| Whitehawk Therapeutics | 192.28M |